• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Humacyte

HydroCision names Tranchemontagne as CEO | Personnel Moves – March 12, 2019

March 12, 2019 By Fink Densford

HydroCision said early this month that it tapped former Smith & Nephew (NYSE:SNN) exec Alain Tranchemontagne as its new chief executive officer. Prior to joining Boston-based HydroCision, Tranchemontagne held a position as U.S. business commercial development senior VP at Smith & Nephew. Before joining Smith & Nephew, Tranchemontagne also held positions at Covidien in senior marketing roles […]

Filed Under: Business/Financial News Tagged With: Aethlon Medical Inc., camberspine, Humacyte, HydroCision Inc., Invictus Medical, IRRAS, Johnson and Johnson, MediWounds, qureai, Senseonics, Smith & Nephew, SynCardia, V-Wave, Virta Health

Humacyte launches Phase II vascular trauma Humacyl vessel trial

October 26, 2018 By Fink Densford

Humacyte said yesterday it launched a U.S. Phase II trial of its Humacyl investigational human acellular vessel exploring the systems’ use for vascular replacement or reconstruction in patients with life or limb-threatening vascular trauma. The Research Triangle Park, N.C.-based company said it hopes to enroll 40 adult patients at six U.S. sites for the trial, […]

Filed Under: Clinical Trials, Featured, Vascular Tagged With: Humacyte

Fresenius Medical Care, Humacyte ink $150m strategic partnership deal

June 11, 2018 By Fink Densford

Fresenius Medical Care (NYSE:FMS; ETR:FRE) said today it inked a $150 million strategic partnership deal with Humacyte through which Fresenius will gain exclusive rights to commercialize Humacyte’s Humacyl bioengineered blood vessel technology. Research Triangle Park, N.C.-based Humacyte is exploring the use of its Humacyl human acellular vessel as a conduit for hemodialysis in patients with end-stage renal […]

Filed Under: Blood Management, Business/Financial News, Vascular Tagged With: Fresenius, Humacyte

Cardinal Health, Hamilton Medical, Zoll Medical score DoD contracts

October 2, 2017 By Chris Newmarker

Cardinal Health (NYSE: CAH) will receive $29.2 million under a new U.S. Department of Defense contract, with Hamilton Medical and Zoll Medical also securing contracts in the tens of millions of dollars. Cardinal Health’s contract win, announced Sept. 29, comes nearly eight months after Dublin, Ohio–based Cardinal Health secured a $2.25 billion surgical supplies contract […]

Filed Under: Business/Financial News, News Well Tagged With: Cardinal Health, defensedepartment, Hamilton Medical, Humacyte, Zoll Medical

AlloSource touts completion of bioengineered blood vessels for Humacyte trial

September 14, 2017 By Fink Densford

Tissue-provider AlloSource said this week it completed production of investigational bioengineered blood vessels designed for Humacyte‘s Phase III clinical trial exploring the use of the vessels to improve vascular access for hemodialysis patients with end-stage renal failure. The trail aims to compare the efficacy of the bioengineered human-tissue vessels to current synthetic vessels made from […]

Filed Under: Research & Development, Vascular Tagged With: allosource, Humacyte

9 women medtech leaders you need to know

March 8, 2017 By Danielle Kirsh

Women account for 50.8% of the U.S. population, yet they only represent 14.8%  of all CEOs in the U.S., according to the Center for American Progress. About 78.4% of healthcare industry workers – but only 34.3% of all surgeons and physicians and 15.9% of medical school deans – are women, the center reports. And according to […]

Filed Under: News Well Tagged With: 480 Biomedical, American Well, Humacyte, IBM Watson Health, McKesson, MedTech, Medtronic, MMJ Labs Pain Relief, Stryker, UnitedHealth Group

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS